Sumitomo Pharma Co., Ltd.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is -12.50% vs 1.26% in Dec 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is -109.21% vs -89.94% in Dec 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Dec'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "105,548.00",
          "val2": "120,624.00",
          "chgp": "-12.50%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "89.00",
          "val2": "17,220.00",
          "chgp": "-99.48%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "460.00",
          "val2": "5,138.00",
          "chgp": "-91.05%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-812.00",
          "val2": "8,817.00",
          "chgp": "-109.21%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-46.40%",
          "val2": "98.70%",
          "chgp": "-14.51%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'26",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2026 is 13.66% vs 26.79% in Mar 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2026 is 352.15% vs 107.50% in Mar 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "453,294.00",
          "val2": "398,832.00",
          "chgp": "13.66%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "73,119.00",
          "val2": "47,984.00",
          "chgp": "52.38%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "10,192.00",
          "val2": "8,558.00",
          "chgp": "19.09%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-1,998.00",
          "val2": "-7,497.00",
          "chgp": "73.35%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "106,865.00",
          "val2": "23,635.00",
          "chgp": "352.15%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "115.50%",
          "val2": "56.20%",
          "chgp": "5.93%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ

Mar'26

Dec'25

Change(%)

Net Sales

105,548.00

120,624.00

-12.50%

Operating Profit (PBDIT) excl Other Income

89.00

17,220.00

-99.48%

Interest

460.00

5,138.00

-91.05%

Exceptional Items

0.00

0.00

Consolidate Net Profit

-812.00

8,817.00

-109.21%

Operating Profit Margin (Excl OI)

-46.40%

98.70%

-14.51%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Mar 2026 is -12.50% vs 1.26% in Dec 2025

Consolidated Net Profit

QoQ Growth in quarter ended Mar 2026 is -109.21% vs -89.94% in Dec 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Mar'26

Mar'26

Mar'25

Change(%)

Net Sales

453,294.00

398,832.00

13.66%

Operating Profit (PBDIT) excl Other Income

73,119.00

47,984.00

52.38%

Interest

10,192.00

8,558.00

19.09%

Exceptional Items

-1,998.00

-7,497.00

73.35%

Consolidate Net Profit

106,865.00

23,635.00

352.15%

Operating Profit Margin (Excl OI)

115.50%

56.20%

5.93%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Mar 2026 is 13.66% vs 26.79% in Mar 2025

Consolidated Net Profit

YoY Growth in year ended Mar 2026 is 352.15% vs 107.50% in Mar 2025

All Annual Results